1. Home
  2. BNTC vs IDR Comparison

BNTC vs IDR Comparison

Compare BNTC & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • IDR
  • Stock Information
  • Founded
  • BNTC 1995
  • IDR 1996
  • Country
  • BNTC United States
  • IDR United States
  • Employees
  • BNTC N/A
  • IDR N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • IDR Precious Metals
  • Sector
  • BNTC Health Care
  • IDR Basic Materials
  • Exchange
  • BNTC Nasdaq
  • IDR Nasdaq
  • Market Cap
  • BNTC 365.1M
  • IDR 378.0M
  • IPO Year
  • BNTC N/A
  • IDR N/A
  • Fundamental
  • Price
  • BNTC $13.74
  • IDR $30.16
  • Analyst Decision
  • BNTC Strong Buy
  • IDR Strong Buy
  • Analyst Count
  • BNTC 5
  • IDR 1
  • Target Price
  • BNTC $26.00
  • IDR $17.50
  • AVG Volume (30 Days)
  • BNTC 37.7K
  • IDR 466.9K
  • Earning Date
  • BNTC 09-26-2025
  • IDR 11-03-2025
  • Dividend Yield
  • BNTC N/A
  • IDR N/A
  • EPS Growth
  • BNTC N/A
  • IDR 57.55
  • EPS
  • BNTC N/A
  • IDR 0.64
  • Revenue
  • BNTC N/A
  • IDR $30,496,328.00
  • Revenue This Year
  • BNTC N/A
  • IDR $21.91
  • Revenue Next Year
  • BNTC N/A
  • IDR $5.47
  • P/E Ratio
  • BNTC N/A
  • IDR $46.13
  • Revenue Growth
  • BNTC N/A
  • IDR 59.64
  • 52 Week Low
  • BNTC $8.06
  • IDR $9.67
  • 52 Week High
  • BNTC $17.15
  • IDR $29.69
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 57.61
  • IDR 68.03
  • Support Level
  • BNTC $13.30
  • IDR $27.13
  • Resistance Level
  • BNTC $14.05
  • IDR $29.65
  • Average True Range (ATR)
  • BNTC 0.57
  • IDR 1.76
  • MACD
  • BNTC 0.03
  • IDR -0.04
  • Stochastic Oscillator
  • BNTC 67.72
  • IDR 97.98

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About IDR Idaho Strategic Resources Inc.

Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.

Share on Social Networks: